Next generation sequencing of BRCA genes in glioblastoma multiform Egyptian patients: a pilot study

• Published in: Archives of physiology and biochemistry Vol. 128; no. 3; pp. 809 - 817
• Main Authors: Nageeb, Amira M., Mohamed, Magdy M., Ezz El Arab, Lobna R., Khalifa, Mohamed K., Swellam, Menha
• Format: Journal Article
• Language: English
• Published: England Taylor & Francis 04.05.2022
• Subjects: BRCA genes; Glioblastoma multiform; mutations; NGS; sequencing; tumour suppressor; BRCA genes; mutations; NGS; Glioblastoma multiform; tumour suppressor; sequencing
• ISSN: 1381-3455; 1744-4160
• DOI: 10.1080/13813455.2020.1729814

Germ line mutations of BRCA1 and BRCA2 were correlated with a variety of cancer Authors aimed to use next-generation sequencing (NGS) to detect BRCA1 and BRCA2 germ line mutations in glioblastoma multiform (GBM) Egyptian patients. Genomic DNA was extracted from six GBM cases, amplified using Ion AmpliSeq BRCA1 and BRCA2 panel. DNA libraries were pooled, barcoded and finally sequenced using Ion Torrent Personal Genome Machine sequencer. BRCA1 the previously reported rs1799966, rs1799950, rs16941 were found in five cases and they are in a linkage disequilibrium forming two distinct haplotypes, which might support their role in cancer predisposition. Out of the 18 reported variants in BRCA2, three denovo mutations were detected which leads to frame shift. Further studies on large number of GBM patients and control cases to determine BRCA1 and BRCA2 germline mutations and haplotypes; diagnostic and prognostic role are encouraged.